Ignite Creation Date:
2024-05-06 @ 1:49 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01905592
Status:
TERMINATED
Last Update Posted:
2022-11-15
First Post:
2013-07-18
Brief Title:
A Phase III Trial of Niraparib Versus Physicians Choice in HER2 Negative Germline BRCA Mutation-positive Breast Cancer Patients
Sponsor:
Tesaro Inc
Organization:
Tesaro Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-18
First Submit QC Date:
July 18 2013
Study First Post Date:
2013-07-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-08-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-21
Last Update Post Date:
2022-11-15
Last Update Post Date Type:
ACTUAL